Post-Market Bioequivalence (BE) Studies
Closed Special Notice Posted
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice announces the cancellation of a previously issued contract opportunity titled "Post-Market Bioequivalence (BE) Studies" solicitation number 75F40125R00097, issued by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services. The cancellation was effective November 21, 2025, and represents Amendment Number 2 to the original solicitation. The FDA determined that it no longer requires the described supplies and services related to post-market bioequivalence studies for generic drug products under an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. This Special Notice was posted to SAM.gov in compliance with Federal Acquisition Regulation requirements for public notification of contract cancellations.
The purpose of this notice is to formally terminate the solicitation and notify all potential offerors that no proposals will be accepted, evaluated, or opened for this requirement. All contractors who were in the process of preparing proposals are instructed to immediately cease their proposal preparation work, as the government will not consider any previously submitted or future submissions. There are no eligibility criteria, key deadlines, or requirements for contractors to fulfill, as the contracting opportunity no longer exists. Contractors with questions regarding this cancellation are directed to contact Contracting Officer Ian Weiss or Contract Specialist Telisha Wilson for clarification.
Notice text
This notication serves as a cancellation of a requirement in name FDAFO121683-Post-Market Bioequivalence (BE) Studies
Files
| File | Type | Posted |
|---|---|---|
| SAM-Cancellation Notice.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Special Notice | |
| Post-Market Bioequivalence (BE) Studies | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity